Poseida Therapeutics Announces Leadership Transition

Mark Gergen to assume role of Executive Chairman of the Board of Directors of Poseida; Kristin Yarema, Ph.D., currently President, Cell Therapy, to be appointed President and CEO
SAN DIEGO, Oct. 9,...

Related Keywords

California ,United States ,Stanford University ,Berkeley ,Brent Warner ,Kristin Yarema ,Mark Gergen ,Astellas Pharma ,Nasdaq ,Prnewswire Poseida Therapeutics Inc ,Celiac Disease Foundation ,Linkedin ,University Of California ,Alliance For Regenerative Medicine ,Amgen ,Exchange Commission ,Mckinsey Company ,Novartis ,Poseida Therapeutics Inc ,Executive Chairman ,Cell Therapy ,Chief Executive Officer ,Chief Business Officer ,Chief Financial Officer ,President Gene Therapy ,Chief Commercial Officer ,Vice President ,Therapeutic Area Head ,Global Product Strategy ,Commercial Innovation ,Chemical Engineering ,Regenerative Medicine ,Celiac Disease ,Poseida Therapeutics ,Site Specific Gene Editing System ,Private Securities Litigation Reform Act ,Markets ,